Interestingly, experiments using TIM-3-blocking antibodies partly reversed these effects, suggesting a role for this receptor in the activation and pro-tumorigenic effects of TAMs in thyroid cancer in vitro [72]. This evidence concerns the gene HAVCR2 and thyroid gland carcinoma.